- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04654169
Suprascapular Nerve Block in Addition to Intra-articular Corticosteroid Injection in Adhesive Capsulitis
Effectiveness of Suprascapular Nerve Block in Addition to Intra-articular Corticosteroid Injection in Adhesive Capsulitis: A Double-blind, Randomized Controlled Trial
Adhesive capsulitis is a disease that negatively affects a person's quality of life by causing severe pain and limitation in the movements of the shoulder joint in all directions. Conservative approaches including nonsteroidal anti-inflammatory drugs or oral corticosteroid usage and physiotherapy program are the first choice for the treatment. However, painful exercises usually prevent patients from fully participating in the physiotherapy program. For this reason, interventional procedures such as intra-articular corticosteroid injection (IAI) and suprascapular nerve block (SSNB) are preferred to be applied before the physiotherapy program.
The aim of this study is to reveal both short and long-term effects of SSNB and IAI combination on pain, shoulder range of motion (ROM), disability, and quality of life in patients with adhesive capsulitis. It is hypothesized that the addition of SSNB to IAI results in greater improvements in pain, passive and active shoulder ROMs, disability, and quality of life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adhesive capsulitis (AK), also known as frozen shoulder, is a disease that negatively affects a person's quality of life by causing severe pain and limitation in the movements of the shoulder joint in all directions. Although the underlying etiology is not clear, it may develop as a result of primary (idiopathic) or secondary causes such as diabetes mellitus, malignancy, thyroid dysfunction, hypoadrenalism, Parkinson's disease, stroke, cardiac and pulmonary diseases, or local shoulder problems such as trauma, tendinitis, rupture. Prolonged immobilization after injuries is another important risk factor for adhesive capsulitis. It is more common in women between the ages of 40-60. Conservative approaches including nonsteroidal anti-inflammatory drugs or oral corticosteroid usage and physiotherapy program are the first choice for the treatment. The physiotherapy program consisting range of motion (ROM), stretching and strengthening exercises are often painful and prevent the patient's full participation. For this reason, interventional procedures such as intra-articular corticosteroid injection (IAI) and suprascapular nerve block (SSNB) are preferred to be applied before the physiotherapy program.
The aim of this study is to reveal both short and long-term effects of SSNB and IAI combination on pain, shoulder ROM, disability, and quality of life in patients with adhesive capsulitis. It is hypothesized that the addition of SSNB to IAI results in greater improvements in pain, passive and active shoulder ROMs, disability, and quality of life. The primary outcome measure of the study is determined to be the Shoulder Pain and Disability Index (SPADI), while the secondary outcome measures to be the Numeric Rating Scale (NRS), active and passive ROMs, and the Short Form 36 (SF-36).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34899
- Kardelen Gencer Atalay
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Diagnosis of adhesive capsulitis
- Bening of symptoms at least three months prior
- Having shoulder pain with passive ROM limitation greater than 30° compared to normal values in at least two directions
Exclusion criteria were:
- Adhesive capsulitis stages 3 and 4
- Previous trauma, IAI, or surgery history
- Evidence of complete rotator cuff tear, calcific tendinitis, biceps tendinitis, glenohumeral or acromioclavicular arthritis on magnetic resonance imaging
- Uncontrolled diabetes mellitus
- Known coagulation disorder
- Contraindication to corticosteroid or local anesthetic injection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: The IAI and SSNB group
Ultrasound-guided IAI and SSNB are planned to apply by at least three-year experienced physiatrists.
Patients are planned to initiate a six-week rehabilitation program supervised by the same physiotherapist one day after the intervention.
|
Ultrasound-guided IAI was applied with a posterior glenohumeral joint in-plane injection technique.
Ultrasound-guided SSNB was carried out with a supraspinatus fossa level in-plane injection technique
|
Active Comparator: The only-IAI group
Ultrasound-guided IAI is planned to apply by at least three-year experienced physiatrists.
Patients are planned to initiate a six-week rehabilitation program supervised by the same physiotherapist one day after the intervention.
|
Ultrasound-guided IAI was applied with a posterior glenohumeral joint in-plane injection technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Baseline (T0)
|
The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire consisting of 13 items divided into two subscales varying between 0 to 100, with a higher value indicating worse condition.
|
Baseline (T0)
|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Three weeks after the intervention (T2)
|
The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire consisting of 13 items divided into two subscales varying between 0 to 100, with a higher value indicating worse condition.
|
Three weeks after the intervention (T2)
|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Three months after the intervention (T3)
|
The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire consisting of 13 items divided into two subscales varying between 0 to 100, with a higher value indicating worse condition.
|
Three months after the intervention (T3)
|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Twelve months after the intervention (T4)
|
The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire consisting of 13 items divided into two subscales varying between 0 to 100, with a higher value indicating worse condition.
|
Twelve months after the intervention (T4)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric Rating Scale (NRS)
Time Frame: Baseline (T0)
|
Numeric Rating Scale (NRS) is used to grade pain intensity between 0 (no pain) to 10 (worst pain) by the patient.
|
Baseline (T0)
|
Numeric Rating Scale (NRS)
Time Frame: One hour after the intervention (T1)
|
Numeric Rating Scale (NRS) is used to grade pain intensity between 0 (no pain) to 10 (worst pain) by the patient.
|
One hour after the intervention (T1)
|
Numeric Rating Scale (NRS)
Time Frame: Three weeks after the intervention (T2)
|
Numeric Rating Scale (NRS) is used to grade pain intensity between 0 (no pain) to 10 (worst pain) by the patient.
|
Three weeks after the intervention (T2)
|
Numeric Rating Scale (NRS)
Time Frame: Three months after the intervention (T3)
|
Numeric Rating Scale (NRS) is used to grade pain intensity between 0 (no pain) to 10 (worst pain) by the patient.
|
Three months after the intervention (T3)
|
Numeric Rating Scale (NRS)
Time Frame: Twelve months after the intervention (T4)
|
Numeric Rating Scale (NRS) is used to grade pain intensity between 0 (no pain) to 10 (worst pain) by the patient.
|
Twelve months after the intervention (T4)
|
Short Form-36
Time Frame: Baseline (T0)
|
Short Form-36 (SF-36) is a widely-used and well-documented health-related quality of life index.
The SF-36 consists of 36 questions; It survey has eight sub-dimensions, including physical functioning, role limitations due to physical problems, pain, general health perception, mental health, role limitations due to emotional problems, vitality, and social functioning, which are evaluated individually.
A higher score on a 0-100 scale indicates a better quality of life.
|
Baseline (T0)
|
Short Form-36
Time Frame: Three weeks after the intervention (T2)
|
Short Form-36 (SF-36) is a widely-used and well-documented health-related quality of life index.
The SF-36 consists of 36 questions; It survey has eight sub-dimensions, including physical functioning, role limitations due to physical problems, pain, general health perception, mental health, role limitations due to emotional problems, vitality, and social functioning, which are evaluated individually.
A higher score on a 0-100 scale indicates a better quality of life.
|
Three weeks after the intervention (T2)
|
Short Form-36
Time Frame: Three months after the intervention (T3)
|
Short Form-36 (SF-36) is a widely-used and well-documented health-related quality of life index.
The SF-36 consists of 36 questions; It survey has eight sub-dimensions, including physical functioning, role limitations due to physical problems, pain, general health perception, mental health, role limitations due to emotional problems, vitality, and social functioning, which are evaluated individually.
A higher score on a 0-100 scale indicates a better quality of life.
|
Three months after the intervention (T3)
|
Short Form-36
Time Frame: Twelve months after the intervention (T4)
|
Short Form-36 (SF-36) is a widely-used and well-documented health-related quality of life index.
The SF-36 consists of 36 questions; It survey has eight sub-dimensions, including physical functioning, role limitations due to physical problems, pain, general health perception, mental health, role limitations due to emotional problems, vitality, and social functioning, which are evaluated individually.
A higher score on a 0-100 scale indicates a better quality of life.
|
Twelve months after the intervention (T4)
|
Shoulder range of motion (ROM) evaluated with a handheld goniometer
Time Frame: Baseline (T0)
|
Shoulder range of motion (ROM) will be evaluated with a goniometer in all directions; flexion, extension, abduction, internal and external rotation.
|
Baseline (T0)
|
Shoulder range of motion (ROM) evaluated with a handheld goniometer
Time Frame: One hour after the intervention (T1)
|
Shoulder range of motion (ROM) will be evaluated with a goniometer in all directions; flexion, extension, abduction, internal and external rotation.
|
One hour after the intervention (T1)
|
Shoulder range of motion (ROM) evaluated with a handheld goniometer
Time Frame: Three weeks after the intervention (T2)
|
Shoulder range of motion (ROM) will be evaluated with a goniometer in all directions; flexion, extension, abduction, internal and external rotation.
|
Three weeks after the intervention (T2)
|
Shoulder range of motion (ROM) evaluated with a handheld goniometer
Time Frame: Three months after the intervention (T3)
|
Shoulder range of motion (ROM) will be evaluated with a goniometer in all directions; flexion, extension, abduction, internal and external rotation.
|
Three months after the intervention (T3)
|
Shoulder range of motion (ROM) evaluated with a handheld goniometer
Time Frame: Twelve months after the intervention (T4)
|
Shoulder range of motion (ROM) will be evaluated with a goniometer in all directions; flexion, extension, abduction, internal and external rotation.
|
Twelve months after the intervention (T4)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ilker Yagci, Prof, Marmara University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.2018.836
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesive Capsulitis of the Shoulder
-
Akin CilTerminatedAdhesive Capsulitis of the ShoulderUnited States
-
University of FloridaCompletedAdhesive Capsulitis of the ShoulderUnited States
-
Kartal City HospitalRecruiting
-
Daniel G. RendeiroCompletedAdhesive Capsulitis of Shoulder | Frozen Shoulder | Shoulder Adhesive CapsulitisUnited States
-
Vanderbilt University Medical CenterOrthopedic Research and Education FoundationCompletedAdhesive Capsulitis | Frozen Shoulder | Adhesive Capsulitis of Unspecified ShoulderUnited States
-
University of VirginiaRecruitingAdhesive Capsulitis of Shoulder | Adhesive Capsulitis | Frozen ShoulderUnited States
-
University of MalayaNot yet recruitingAdhesive Capsulitis of Shoulder
-
Taipei Veterans General Hospital, TaiwanRecruitingAdhesive Capsulitis of ShoulderTaiwan
-
Taif UniversityRecruitingAdhesive Capsulitis of ShoulderSaudi Arabia
-
Cairo UniversityNot yet recruitingAdhesive Capsulitis of Shoulder
Clinical Trials on Ultrasound-guided IAI
-
Abant Izzet Baysal UniversityRecruiting
-
Tri-Service General HospitalCompleted
-
Jose Antonio Garcia VidalUniversidad de MurciaCompleted
-
Bracco Diagnostics, IncBracco Imaging S.p.A.TerminatedProstate CancerItaly, Austria, France, Netherlands, Belgium, Germany, United Kingdom
-
University of AlcalaActive, not recruiting
-
University of California, San FranciscoCompletedUterine FibroidsUnited States
-
University Medical Center of Southern NevadaCompleted
-
Kasr El Aini HospitalCompleted
-
Tri-Service General HospitalCompletedCarpal Tunnel SyndromeTaiwan
-
Menoufia UniversityAlexandria UniversityCompleted